Status:
NOT_YET_RECRUITING
EUS- and US- Guided Biopsy for Pancreatic Lesion
Lead Sponsor:
Tian'an Jiang
Conditions:
Pancreatic Cancer
Eligibility:
All Genders
18-85 years
Brief Summary
Endoscopic ultrasound (EUS) and ultrasound (US) are the two primary imaging modalities used to guide pancreatic needle biopsy. This study aimed to compare the diagnostic performance and complications ...
Eligibility Criteria
Inclusion
- Between January 2017 and December 2023, 2663 consecutive patients with focal pancreatic disease underwent 2729 procedures for pancreatic tissue acquisition from focal pancreatic lesions at seven university teaching hospitals in China.
Exclusion
- Patients were excluded from the study if they had less than 12 months of follow-up, were lost to follow-up, had incomplete follow-up data, or underwent intraoperative biopsy or fluid aspiration.
Key Trial Info
Start Date :
August 18 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
2517 Patients enrolled
Trial Details
Trial ID
NCT07138976
Start Date
August 18 2025
End Date
December 31 2025
Last Update
August 24 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.